PD-1 inhibitor therapy(Shanghai Chest Hospital)

N/A

Report date: 2023/12/19 20:05:05

Base Information

Drug NamePD-1 inhibitor therapy(Shanghai Chest Hospital)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 inhibitors
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsEsophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Chest Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Chest Hospital
Inactive CompaniesN/A
Active IndicationsEsophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A